790 related articles for article (PubMed ID: 32126303)
41. Gut microbiome approaches to treat obesity in humans.
Bianchi F; Duque ALRF; Saad SMI; Sivieri K
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
[TBL] [Abstract][Full Text] [Related]
42. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
Caesar R
Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
[TBL] [Abstract][Full Text] [Related]
43. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
[TBL] [Abstract][Full Text] [Related]
44. Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S; Tripathi P
J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
[TBL] [Abstract][Full Text] [Related]
45. Probiotics, prebiotics and colorectal cancer prevention.
Ambalam P; Raman M; Purama RK; Doble M
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
[TBL] [Abstract][Full Text] [Related]
46. Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.
Ganesan K; Chung SK; Vanamala J; Xu B
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467295
[TBL] [Abstract][Full Text] [Related]
47. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
Baldi S; Mundula T; Nannini G; Amedei A
World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
[TBL] [Abstract][Full Text] [Related]
48. Rebuilding the Gut Microbiota Ecosystem.
Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
[TBL] [Abstract][Full Text] [Related]
49. Gut microbiota: a target for intervention in obesity.
Sehgal K; Khanna S
Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
[TBL] [Abstract][Full Text] [Related]
50. The Gut Microbiota: The Gateway to Improved Metabolism.
Martinez KB; Pierre JF; Chang EB
Gastroenterol Clin North Am; 2016 Dec; 45(4):601-614. PubMed ID: 27837775
[TBL] [Abstract][Full Text] [Related]
51. From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy.
Brenchley JM; Serrano-Villar S
Microbiome; 2024 Jun; 12(1):113. PubMed ID: 38907315
[TBL] [Abstract][Full Text] [Related]
52. Faecal microbiota transplantation is better than probiotics for tissue regeneration of type 2 diabetes mellitus injuries in mice.
Wang Y; Yang Z; Tang H; Sun X; Qu J; Lu S; Rao B
Arch Physiol Biochem; 2024 Jun; 130(3):333-341. PubMed ID: 35675471
[TBL] [Abstract][Full Text] [Related]
53. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
[TBL] [Abstract][Full Text] [Related]
54. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
[TBL] [Abstract][Full Text] [Related]
55. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.
Holmes A; Finger C; Morales-Scheihing D; Lee J; McCullough LD
Transl Res; 2020 Dec; 226():39-56. PubMed ID: 32755639
[TBL] [Abstract][Full Text] [Related]
56. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review.
Mincic AM; Antal M; Filip L; Miere D
Clin Nutr; 2024 Jul; 43(7):1832-1849. PubMed ID: 38878554
[TBL] [Abstract][Full Text] [Related]
57. Classical methods and perspectives for manipulating the human gut microbial ecosystem.
Jiménez-Avalos JA; Arrevillaga-Boni G; González-López L; García-Carvajal ZY; González-Avila M
Crit Rev Food Sci Nutr; 2021; 61(2):234-258. PubMed ID: 32114770
[TBL] [Abstract][Full Text] [Related]
58. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
59. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
60. The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
Varesi A; Pierella E; Romeo M; Piccini GB; Alfano C; Bjørklund G; Oppong A; Ricevuti G; Esposito C; Chirumbolo S; Pascale A
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
